Cuba is producing an 18F-fluorodeoxyglucose (18F-FDG) molecule, a radiopharmaceutical that stands out for its effectiveness in detecting tumors and other diseases.
The Biotechnological and Pharmaceutical Industries Group (BioCubaFarma) signed a new cooperation agreement with Chinese joint venture Changheber for the introduction of innovative immunotherapy for the treatment of cancer in the Asian country, it announced via Twitter.
The scientific magazine Vaccines highlighted that an article on Cuba's therapeutic vaccine, known as Nasvac, against hepatitis B today has a great impact internationally.
The 46th Edition of the Province's Annual Health Award Contest 2023, awarded 25 works by professionals, technicians and students presented in the final scientific contest, which on this occasion was distinguished by the number of participants and broad representation achieved by Primary Health Care (PHC).
The province of Holguín closed the month of May with an increase in patients with COVID-19, reporting 203 cases, of which 200 were autochthonous, for an incidence rate of 19.8 per 100,000 inhabitants.